253 related articles for article (PubMed ID: 31773415)
1. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
[TBL] [Abstract][Full Text] [Related]
3. CXCR7 expression in esophageal cancer.
Tachezy M; Zander H; Gebauer F; von Loga K; Pantel K; Izbicki JR; Bockhorn M
J Transl Med; 2013 Sep; 11():238. PubMed ID: 24074251
[TBL] [Abstract][Full Text] [Related]
4. IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis.
Inoue M; Takeuchi H; Matsuda S; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Kitagawa Y
Anticancer Res; 2021 Feb; 41(2):783-794. PubMed ID: 33517283
[TBL] [Abstract][Full Text] [Related]
5. Targeting chemokine pathways in esophageal adenocarcinoma.
Shrivastava MS; Hussain Z; Giricz O; Shenoy N; Polineni R; Maitra A; Verma A
Cell Cycle; 2014; 13(21):3320-7. PubMed ID: 25485576
[TBL] [Abstract][Full Text] [Related]
6. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
7. Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives.
Łukaszewicz-Zając M; Mroczko B; Szmitkowski M
Tumour Biol; 2015 Aug; 36(8):5707-14. PubMed ID: 26130416
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma.
Goto M; Shibahara Y; Baciu C; Allison F; Yeung JC; Darling GE; Liu M
Ann Surg Oncol; 2021 Sep; 28(9):4943-4951. PubMed ID: 33709176
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract][Full Text] [Related]
10. CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.
Uchi Y; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2016 Jul; 16():514. PubMed ID: 27439769
[TBL] [Abstract][Full Text] [Related]
11. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
[TBL] [Abstract][Full Text] [Related]
12. ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.
Tungekar A; Mandarthi S; Mandaviya PR; Gadekar VP; Tantry A; Kotian S; Reddy J; Prabha D; Bhat S; Sahay S; Mascarenhas R; Badkillaya RR; Nagasampige MK; Yelnadu M; Pawar H; Hebbar P; Kashyap MK
Sci Rep; 2018 Aug; 8(1):12715. PubMed ID: 30143675
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma.
Yang X; Lu Q; Xu Y; Liu C; Sun Q
Pathol Res Pract; 2020 Jan; 216(1):152787. PubMed ID: 31859114
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
17. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma.
Ogura M; Takeuchi H; Kawakubo H; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Miyasho T; Yamada S; Kitagawa Y
Surgery; 2013 Sep; 154(3):512-20. PubMed ID: 23972657
[TBL] [Abstract][Full Text] [Related]
19. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z
Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250
[TBL] [Abstract][Full Text] [Related]
20. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]